tirzepatide va zepbound FDA approves new obesity drug from Eli Lilly named VA Expands Access to Zepbound

Is tirzepatide or semaglutide better for weight loss in obese patients

Side effects are a normal part of the adjustment process

Throughout your weight-care experience, your doctor at Alloy will remain your doctor, and youll be able to message them at any time

According to the FDA, tirzepatide (marketed as Mounjaro and Zepbound) carries a label warning that animal studies showed risk to the fetus, and the drug should only be used during pregnancy if the potential benefit outweighs the risk with safer, better-studied alternatives usually preferred

To address this, we conducted a systematic review and network meta-analysis (NMA) examining RCTs of patients with T2D and ASCVD or high CV risk, with two primary objectives: (1) To perform a class-level NMA to evaluate the effect of tirzepatide compared with placebo on cardiovascular outcomes

are employed by Eli Lilly and Company